Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis.

CONCLUSION: The IL-23p19 blockers have excellent efficacy and great safety in plaque psoriasis patients, but long-term safety remains to be determined.
PMID: 31465912 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - August 25, 2019 Category: Allergy & Immunology Authors: Xu S, Zhang X, Pan M, Shuai Z, Xu S, Pan F Tags: Int Immunopharmacol Source Type: research